Victoria’s Secret and Pelotonia Present Scientific Achievement Awards to Women in Cancer Research
April 13 2022 - 8:00AM
Victoria's Secret and impact partner Pelotonia presented five
female cancer researchers with scientific achievement awards of
$100,000 each at the American Association for Cancer Research
(AACR) Annual Meeting this past weekend. The Victoria’s Secret
Global Fund for Women’s Cancers 2022 Meritorious Awards, in
partnership with Pelotonia and AACR, recognizes and furthers their
outstanding contributions to the field of women’s cancers. This is
the inaugural award provided by The Fund, which will award $5
million annually to women scientists studying women’s cancers and
build on more than $21 million already raised for innovative cancer
research by Victoria’s Secret since 2011.
“We have long supported cancer research, but this particular
program – accelerating innovation in cancer research for women, by
women – is a tangible way we’re bringing to life our brand’s vision
of being a leading advocate for women,” said Christy Tostevin,
senior vice president of communications and community relations,
Victoria’s Secret. “We are exceptionally proud to share The Fund’s
inaugural award with five outstanding women who have been leading
this critically important work for decades, and are inspiring the
next generation of women leaders in cancer.”
According to the International Agency for Research on Cancer, in
2020 alone more than 9.23 million women worldwide were diagnosed
with cancer – a number that is expected to rise to 10.3 million
women by 2025. Yet research of women’s cancers is historically
under-resourced, and there aren’t enough women driving said
research. The Fund will accelerate innovation in cancer research
for women, by women.
“At Pelotonia, our community has been working tirelessly for
more than a decade to fuel scientific breakthroughs; we’re thrilled
to partner with Victoria’s Secret in this exciting new initiative
that will fund critical research in the field of women’s cancers
while also building an essential collaborative platform that will
accelerate the achievements of the award recipients and the next
generation of researchers,” said Alida Smith, chief marketing
officer, Pelotonia. “Much needed financial support, combined with a
focused, driven desire between multiple organizations to change the
outcome for so many people who will be diagnosed with cancer in the
future, will result in massive global impact.”
Recipients of the inaugural scientific achievement awards
include:
- Joan S. Brugge, PhD, FAACR Harvard Medical
School, Boston, MassachusettsFor lifelong investigations dedicated
to unraveling breast cancer initiation, progression and drug
resistance that contribute to human carcinogenesis.
- Susan M. Domchek, MD University of
Pennsylvania, Philadelphia, PennsylvaniaFor demonstrating that
genetic testing for high penetrance breast cancer susceptibility
genes can improve risk assessment, inform appropriate risk
reduction strategies and be used to develop targeted
therapeutics.
- Karen H. Lu, MD The University of Texas MD
Anderson Cancer Center, Houston, TexasFor fundamental studies of
endometrial cancer in Lynch Syndrome, and the prevention of ovarian
and sporadic endometrial cancers.
- Lisa A. Newman, MD, MPH New
York-Presbyterian/Weill Cornell Medical Center, New York, New York
For significantly advancing the understanding of the etiology of
breast cancers in African and African American women.
- Martine J. Piccart, MD, PhD, FAACR Université
Libre de Bruxelles, Brussels, Belgium For visionary and
unparalleled leadership in advancing breast cancer clinical trials
and drug development.
“We were thrilled to recognize these five remarkable female
researchers at this year’s AACR Annual Meeting,” said Margaret
Foti, PhD, MD (hc), chief executive officer, AACR. “Drs. Brugge,
Domchek, Lu, Newman, and Piccart have made seminal contributions to
our progress against breast and gynecologic cancers. Collectively,
their research has deepened our understanding of these diseases,
improved cancer prevention and screening techniques, led to
improvements in medical and surgical treatments and saved countless
lives worldwide.”
In addition to the $100,000 honorarium, each awardee will be
invited to serve as an active participant and mentor in a broader
women’s cancers grant program, which will include multi-year
research grants for both established and early-stage investigators.
This grant program will be funded by The Victoria’s Secret Global
Fund for Women’s Cancers and administered by the AACR and
Pelotonia. All grant recipients of The Fund will be offered a
robust mentorship experience to develop their careers and areas of
expertise, thanks to the support of the five Meritorious Awardees
and The Fund’s world-class Scientific Advisory Council, co-chaired
by Dr. Foti and Electra Paskett, PhD, Director, Center for Cancer
Health Equity at The Ohio State University Comprehensive Cancer
Center – The James.
For more information, please
visit pelotonia.org/vsfund.
About Victoria’s SecretVictoria’s
Secret (NYSE: VSCO) is the world’s largest intimates specialty
retailer offering a wide assortment of modern, fashion-inspired
collections including signature bras, panties, lingerie, casual
sleepwear and athleisure, as well as award-winning prestige
fragrances and body care. With nearly 1,400 retail stores worldwide
and a predominately female workforce of more than 30,000,
Victoria’s Secret boasts the largest team of specialty trained bra
fit experts worldwide. Victoria’s Secret is committed to inspiring
women around the world with products and experiences that uplift
and champion them and their journey while creating lifelong
relationships and advocating for positive change.
About PelotoniaPelotonia exists to engage,
inspire, and challenge a community committed to change the world by
accelerating innovative cancer research. Since its founding in
2008, Pelotonia has raised over $236 million for cancer research
which has been invested in high-impact breakthroughs in prevention,
diagnostics and treatment, and recently, the launch of The
Pelotonia Institute for Immuno-Oncology. Thanks to its generous
funding partners, Pelotonia is able to direct 100 percent of every
community-raised dollar from its annual cycling event to cancer
research at The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove Institute.
For more information, visit pelotonia.org.
About the American Association for Cancer
ResearchFounded in 1907, the American Association for
Cancer Research (AACR) is the world’s first and largest
professional organization dedicated to advancing cancer research
and its mission to prevent and cure cancer. AACR membership
includes more than 50,000 laboratory, translational, and
clinical researchers; population scientists; other health care
professionals; and patient advocates residing in 129 countries. The
AACR marshals the full spectrum of expertise of the cancer
community to accelerate progress in the prevention, diagnosis, and
treatment of cancer by annually convening more than 30 conferences
and educational workshops—the largest of which is the AACR Annual
Meeting, with more than 74,000 attendees for the 2020 virtual
meetings and more than 22,500 attendees for past in-person
meetings. In addition, the AACR publishes 10 prestigious,
peer-reviewed scientific journals and a magazine for cancer
survivors, patients, and their caregivers. The AACR funds
meritorious research directly as well as in cooperation with
numerous cancer organizations. As the Scientific Partner of Stand
Up To Cancer, the AACR provides expert peer review, grants
administration, and scientific oversight of team science and
individual investigator grants in cancer research that have the
potential for near-term patient benefit. The AACR actively
communicates with legislators and other policymakers about the
value of cancer research and related biomedical science in saving
lives from cancer. For more information about the AACR,
visit www.AACR.org.
Contacts |
|
Gabby BlauertPelotonia(708) 629-9618
cellgblauert@pelotonia.org |
Brooke WilsonVictoria’s Secret &
Co.communications@victoria.com |
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/ed293a6c-6eb4-47ab-bc2a-d1991c704350
Victoria's Secret (NYSE:VSCO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Victoria's Secret (NYSE:VSCO)
Historical Stock Chart
From Jul 2023 to Jul 2024